CicchettiS.JemecB.GaultD.T.: Two case reports of vinorelbine extravasation: management and review of the literature.Tumori, 86: 289–292, 2000.
2.
BertelliG.DiniD.FornoG.B.GozzaA.SilvestroS.VenturiniM.RossoR.PronzatoP.: Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results.J Cancer Res Clin Oncol, 120: 505–506, 1994.
3.
DorrR.T.AlbertsD.S.: Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.J Natl Cancer Inst, 74: 113–120, 1985.
4.
BertelliG.CafferataM.A.ArdizzoniA.GozzaA.RossoR.DiniD.: Skin ulceration potential of paclitaxel in a mouse skin model in vivo.Cancer, 79: 2266–2268, 1997 (letter).
5.
BertelliG.GozzaA.FornoG.B.VidiliM.G.SilvestroS.VenturiniM.Del MastroL.GarroneO.RossoR.DiniD.: Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical study.J Clin Oncol, 13: 2851–2855, 1995.
6.
BertelliG.: Prevention and management of extravasation of cytotoxic drugs.Drug Safety, 12: 245–255, 1995.